• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 1 Device Recall CyPass MicroStent, Model 241S

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 1 Device Recall CyPass MicroStent, Model 241Ssee related information
Date Initiated by FirmAugust 28, 2018
Date PostedOctober 23, 2018
Recall Status1 Terminated 3 on December 18, 2020
Recall NumberZ-0185-2019
Recall Event ID 80931
PMA NumberP150037 
Product Classification Intraocular pressure lowering implant - Product Code OGO
ProductCyPass System 241-S, CYPASS MICRO-STENT, CYPASS LOADED, CYPASS APPLIER, REF CATALOG #: 8065754003 For ophthalmic use.
Code Information GTIN: 00380657540037 All lot/serial numbers
Recalling Firm/
Manufacturer
Alcon Research, LTD.
714 Columbia Ave
Sinking Spring PA 19608-1405
For Additional Information ContactCustomer Services
800-862-5266
Manufacturer Reason
for Recall
Analysis of the completed dataset from the COMPASS-XT long-term study showed that the CyPass Micro-Stent group experienced statistically significant endothelial cell loss (ECL) compared to the group who underwent cataract surgery alone.
FDA Determined
Cause 2
Device Design
ActionThe firm initiated their market withdrawal by letter on 08/28/2018. The firm requested surgeons immediately cease implantation of the device and return any unused product.
Quantity in Commerce30561 units
DistributionWorldwide distribution. US nationwide including Puerto Rico, Argentina, Australia, Austria, Canada, Chile, Colombia, Costa Rica, Denmark, Dominican Republic, Ecuador, France, Finland, Germany, Hong Kong, Iceland, Italy, Mexico, Peru, Singapore, Spain, Sweden, Switzerland, United Kingdom, and Uruguay.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
PMA DatabasePMAs with Product Code = OGO
-
-